The quickly-binding biologic lonigutamab demonstrated initial success in improving signs and symptoms of thyroid eye disease ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

We found the following factors were important for predicting the progression of glaucoma: (1) the presence of small bleeding and poor blood flow to the retina and back of the eye, (2) abnormal cell ...

Bri Rodriguez [email protected] Glaucoma, often called the “silent thief of vision,” is the second leading cause of ...

In a survey, nearly two-thirds of patients with glaucoma or ocular hypertension were unaware of preservative-free topical ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment ...

A new analysis linking clinical and census data finds individual factors, rather than neighborhood conditions, are more strongly associated ...

Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing loss are all ...

The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...